other material
confidence high
sentiment positive
materiality 0.65
Intensity Therapeutics raises $6.6M via ATM stock sales; cash runway extended to H2 2026
INTENSITY THERAPEUTICS, INC.
- Gross proceeds of $6.6M ($6.3M net) from sale of 19,868,658 shares at avg $0.3323/share in July 2025.
- Shares outstanding post-ATM: 46,035,081 as of July 31, 2025.
- Average price per share >10% higher than June 2025 public offering, reducing dilution cost.
- Proceeds extend cash runway into second half of 2026 to advance clinical trials.